SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 53 filers reported holding SPERO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6 | -99.8% | 4 | -99.9% | 0.00% | – |
| Q2 2022 | $3,000 | +200.0% | 4,120 | +3900.0% | 0.00% | – |
| Q1 2022 | $1,000 | -99.2% | 103 | -98.8% | 0.00% | – |
| Q1 2021 | $126,000 | -24.1% | 8,552 | 0.0% | 0.00% | – |
| Q4 2020 | $166,000 | +38.3% | 8,552 | -20.5% | 0.00% | – |
| Q3 2020 | $120,000 | -78.7% | 10,752 | -74.2% | 0.00% | – |
| Q2 2020 | $564,000 | -29.5% | 41,652 | -57.9% | 0.00% | – |
| Q1 2020 | $800,000 | -15.9% | 98,952 | 0.0% | 0.00% | – |
| Q4 2019 | $951,000 | -47.4% | 98,952 | -42.0% | 0.00% | – |
| Q3 2019 | $1,808,000 | -31.4% | 170,588 | -25.5% | 0.00% | – |
| Q2 2019 | $2,635,000 | -47.2% | 228,952 | -41.2% | 0.00% | -100.0% |
| Q1 2019 | $4,986,000 | +65.9% | 389,252 | -20.3% | 0.00% | – |
| Q4 2018 | $3,005,000 | -53.7% | 488,552 | -21.0% | 0.00% | -100.0% |
| Q3 2018 | $6,497,000 | -44.6% | 618,206 | -22.7% | 0.00% | 0.0% |
| Q2 2018 | $11,736,000 | +2.9% | 800,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,400,000 | +21.3% | 800,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,400,000 | – | 800,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $14,596,000 | 24.02% |
| Aquilo Capital Management, LLC | 1,154,356 | $12,236,000 | 8.62% |
| VHCP Management II, LLC | 474,015 | $5,025,000 | 1.92% |
| AWM Investment Company, Inc. | 598,315 | $6,342,000 | 1.35% |
| BVF INC/IL | 939,704 | $9,961,000 | 1.05% |
| Novo Holdings A/S | 465,983 | $4,939,000 | 0.85% |
| Alphabet Inc. | 1,112,473 | $11,792,000 | 0.35% |
| Artal Group S.A. | 540,000 | $5,724,000 | 0.23% |
| Rock Springs Capital Management LP | 525,000 | $5,565,000 | 0.22% |
| DAFNA Capital Management LLC | 39,395 | $418,000 | 0.16% |